Scholarlink

<p><i>Boswellia serrata</i> is a medicinal plant traditionally used to treat inflammatory conditions and this study aimed to evaluate the efficacy of <i>B. serrata</i> dry extract (BSDE) in treating gastric ulcers and ulcerative colitis. Chronic gastric ulcers were induced using 80% acetic acid. For seven days, rats were given oral doses of BSDE (30, 100, or 300&#xa0;mg/kg), omeprazole (40&#xa0;mg/kg), or vehicle. Ulcer area, mucin content, and biochemical indicators (GSH, SOD, CAT, GST, MPO, MDA) were evaluated. The rectal administration of 8% acetic acid produced ulcerative colitis. BSDE (100 or 300&#xa0;mg/kg), dexamethasone (2&#xa0;mg/kg), or vehicle were given three days before and after colitis induction. Colonic damage was assessed macroscopically and microscopically, as well as mucin production and indicators of oxidative stress. Finally, computational investigations were carried out to identify potential pharmacological targets. BSDE was analyzed using ESI–MS, revealing the presence of six compounds, including α-boswellic acid and keto-boswellic acid. In the gastric ulcer model, oral administration of BSDE for seven days accelerated the ulcer healing, with the 100&#xa0;mg/kg dose being the most effective. BSDE enhanced gastric mucin content and reduced oxidative stress. In the colitis model, BSDE reduced macroscopic damage, preserved crypt architecture, and decreased inflammatory infiltration. Computational investigations identified potential pharmacological targets for BSDE constituents, including COX-1 and 2, and iNOS. BSDE also demonstrated good ADME features and a favorable toxicity profile. The results suggest that BSDE exerts gastroprotective and intestinal anti-inflammatory effects through antioxidant and mucosal protective mechanisms. These findings support the traditional use of <i>B. serrata</i> as a viable therapeutic option for gastrointestinal diseases, highlighting its potential as a phytotherapeutic agent.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Boswellia serrata dry extract with intestinal anti-inflammatory properties also accelerates gastric ulcer healing in rats

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月27日

查看全文
  • Franco Giovanni Sandri Serafim,
  • Lucas Fontana Breguez da Cunha,
  • Larissa Venzon,
  • Ana Carolina dos Santos Nilz,
  • Bruna Longo,
  • Ruan Kaio Silva Nunes,
  • Max Vidal Gutiérrez,
  • Daniela Miorando,
  • Cristian A. Dalla Vecchia,
  • Walter Antônio Roman Junior,
  • Luisa Mota da Silva

摘要

Boswellia serrata is a medicinal plant traditionally used to treat inflammatory conditions and this study aimed to evaluate the efficacy of B. serrata dry extract (BSDE) in treating gastric ulcers and ulcerative colitis. Chronic gastric ulcers were induced using 80% acetic acid. For seven days, rats were given oral doses of BSDE (30, 100, or 300 mg/kg), omeprazole (40 mg/kg), or vehicle. Ulcer area, mucin content, and biochemical indicators (GSH, SOD, CAT, GST, MPO, MDA) were evaluated. The rectal administration of 8% acetic acid produced ulcerative colitis. BSDE (100 or 300 mg/kg), dexamethasone (2 mg/kg), or vehicle were given three days before and after colitis induction. Colonic damage was assessed macroscopically and microscopically, as well as mucin production and indicators of oxidative stress. Finally, computational investigations were carried out to identify potential pharmacological targets. BSDE was analyzed using ESI–MS, revealing the presence of six compounds, including α-boswellic acid and keto-boswellic acid. In the gastric ulcer model, oral administration of BSDE for seven days accelerated the ulcer healing, with the 100 mg/kg dose being the most effective. BSDE enhanced gastric mucin content and reduced oxidative stress. In the colitis model, BSDE reduced macroscopic damage, preserved crypt architecture, and decreased inflammatory infiltration. Computational investigations identified potential pharmacological targets for BSDE constituents, including COX-1 and 2, and iNOS. BSDE also demonstrated good ADME features and a favorable toxicity profile. The results suggest that BSDE exerts gastroprotective and intestinal anti-inflammatory effects through antioxidant and mucosal protective mechanisms. These findings support the traditional use of B. serrata as a viable therapeutic option for gastrointestinal diseases, highlighting its potential as a phytotherapeutic agent.